Angiotensin type-1-receptor antagonists reduce 6-hydroxydopamine toxicity for dopaminergic neurons.

Rey P, Lopez-Real A, Sanchez-Iglesias S, Muñoz A, Soto-Otero R, Labandeira-Garcia JL

Open source

DOI
10.1016/j.neurobiolaging.2006.02.018
Published
2007 Apr
Container
Neurobiology of aging
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.neurobiolaging.2006.02.018,
  title = {Angiotensin type-1-receptor antagonists reduce 6-hydroxydopamine toxicity for dopaminergic neurons.},
  author = {Rey P and Lopez-Real A and Sanchez-Iglesias S and Muñoz A and Soto-Otero R and Labandeira-Garcia JL},
  year = {2007},
  journal = {Neurobiology of aging},
  doi = {10.1016/j.neurobiolaging.2006.02.018},
  url = {https://doi.org/10.1016/j.neurobiolaging.2006.02.018}
}

RIS

TY  - JOUR
TI  - Angiotensin type-1-receptor antagonists reduce 6-hydroxydopamine toxicity for dopaminergic neurons.
AU  - Rey P
AU  - Lopez-Real A
AU  - Sanchez-Iglesias S
AU  - Muñoz A
AU  - Soto-Otero R
AU  - Labandeira-Garcia JL
PY  - 2007
JO  - Neurobiology of aging
DO  - 10.1016/j.neurobiolaging.2006.02.018
UR  - https://doi.org/10.1016/j.neurobiolaging.2006.02.018
ER  - 

APA

P, R., A, L., S, S., A, M., R, S., & JL, L. (2007). Angiotensin type-1-receptor antagonists reduce 6-hydroxydopamine toxicity for dopaminergic neurons.. Neurobiology of aging. https://doi.org/10.1016/j.neurobiolaging.2006.02.018

Source records